Journal: BioMed Research International

Article Title: Identification of Key Genes in the Response to Salmonella enterica Enteritidis , Salmonella enterica Pullorum , and Poly(I:C) in Chicken Spleen and Caecum

doi: 10.1155/2014/154946

Figure Lengend Snippet: qRT-PCR results of five DEGs selected from microarray data. ( P value ≤ 0.05).

Article Snippet: Subsequently, spleen and caecum samples of four individuals from each group with intact experimental records were randomly selected and sent to Shanghai Biotechnology Co., Ltd. (SBC), which performed the microarray test.

Techniques: Microarray, Expressing

Journal: Translational Oncology

Article Title: Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

doi: 10.1016/j.tranon.2019.08.008

Figure Lengend Snippet: MammaPrint (MP) microarray indices assessed at Agendia Amsterdam central laboratory in comparison to MP NGS indices at the beta sites. The comparison shows equivalence between the two technologies (Pearson's r = 0.96). The x-axis reports the MP microarray index, the y-axis reports the MP NGS index. Each dot represents a single breast cancer sample for which total RNA underwent microarray and NGS laboratory processing and analysis. The blue dots represent the discordant cases with indices close to the classification threshold.

Article Snippet: The current MP and BP gold standard FFPE microarray test was recently successfully translated to a targeted RNA NGS based test at Agendia laboratories .

Techniques: Microarray, Comparison

Journal: Translational Oncology

Article Title: Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

doi: 10.1016/j.tranon.2019.08.008

Figure Lengend Snippet: Comparison of test outcomes from MammaPrint (High/Low Risk) between microarray assessed at Agendia Amsterdam central laboratory and NGS assessed at the beta sites. These results show a Negative Predictive Agreement (Low Risk) of 93.8% (60/64, 95% CI: 85.0–97.5), a Positive Predictive Agreement (High Risk) of 88.3% (53/60, 95% CI: 77.8–94.2), a concordance of 91.1% and a Cohen's kappa of 0.82.

Article Snippet: The current MP and BP gold standard FFPE microarray test was recently successfully translated to a targeted RNA NGS based test at Agendia laboratories .

Techniques: Comparison, Microarray

Journal: Translational Oncology

Article Title: Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

doi: 10.1016/j.tranon.2019.08.008

Figure Lengend Snippet: Comparison of molecular subtyping using MP and BP tests (Luminal A for Low Risk MP and Luminal B for High Risk) between NGS Beta Site and IHC according to Prat et al. (n = 124) ( A ), between NGS Beta Site and IHC according to Maisonneuve et al. (n = 124) ( B ), between NGS Beta Site and microarray Agendia (n = 124) ( C ), and between NGS Beta Site and NGS Agendia (n = 114 ∗ ) ( D ). These results show a concordance of 71.8% (89/124) ( A ), 76.6% (95/124) ( B ), 89.5% (111/124) ( C ) and 93.9% (107/114) ( D ).

Article Snippet: The current MP and BP gold standard FFPE microarray test was recently successfully translated to a targeted RNA NGS based test at Agendia laboratories .

Techniques: Comparison, Microarray

Journal: Translational Oncology

Article Title: Decentralization of Next-Generation RNA Sequencing-Based MammaPrint® and BluePrint® Kit at University Hospitals Leuven and Curie Institute Paris

doi: 10.1016/j.tranon.2019.08.008

Figure Lengend Snippet: MammaPrint (MP) NGS indices assessed at Agendia Amsterdam central laboratory in comparison to MP NGS at the beta sites. The comparison shows equivalence between MP NGS performed at Agendia (x-axis) and MP NGS at the beta sites (y-axis) (Pearson's r = 0.96) (n = 114). Each dot represents a single breast cancer sample for which total RNA underwent NGS or microarray laboratory processing and analysis. Out of the 124 samples processed on NGS, 10 samples lacked NGS results at Agendia. The blue dots represent the discordant cases with indices close to the classification threshold.

Article Snippet: The current MP and BP gold standard FFPE microarray test was recently successfully translated to a targeted RNA NGS based test at Agendia laboratories .

Techniques: Comparison, Microarray

Journal: Molecular Genetics & Genomic Medicine

Article Title: Collaborations in medical genetics: 10‐Year history of an ongoing Vietnamese‐North American Collaboration

doi: 10.1002/mgg3.383

Figure Lengend Snippet: Undiagnosed genetic disorders in Vietnam

Article Snippet: In 2011, we collaborated with BlueGnome to use DNA obtained from 20 patients with suspected underlying genetic disorders (UGD) that had been evaluated in Genetics Clinic at Hue College of Medicine and Pharmacy using spit samples and blood samples for DNA microarray testing.

Techniques: Microarray, Sequencing, Diagnostic Assay